Areas of Focus
- Tumor Immunotherapy
- Pulmonary Fibrosis Immunotherapy
Academic Background & Achievements
- 2017 - PhD: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- Published 5 papers as first or co-first author with a cumulative impact factor of 61.97
Publications
- Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases, Lai Y, Wei X, Ye T, Hang L, Mou L, Su J, 2021
- Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells, Lai Y, Weng J, Wei X, Qin L, Lai P, Zhao R, Jiang Z, Li B, Lin S, Wang S et al, 2018
- Current status and perspectives of patient-derived xenograft models in cancer research, Lai Y, Wei X, Lin S, Qin L, Cheng L, Li P, 2017
- PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells, Wei X, Lai Y, Li J, Qin L, Xu Y, Zhao R, Li B, Lin S, Wang S, Wu Q et al, 2017
- Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells, Qin L, Lai Y, Zhao R, Wei X, Weng J, Lai P, Li B, Lin S, Wang S, Wu Q et al, 2017